$325 Million is the total value of WELCH CAPITAL PARTNERS LLC/NY's 35 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VOO | Sell | VANGUARD INDEX FDS | $117,790,000 | -22.5% | 339,569 | -7.2% | 36.23% | -1.3% |
| SPY | Sell | SPDR S&P 500 ETF TRtr unit | $86,811,000 | -16.5% | 230,114 | -0.0% | 26.70% | +6.3% |
| GOOG | Sell | ALPHABET INCcap stk cl c | $19,055,000 | -21.7% | 8,711 | -0.1% | 5.86% | -0.4% |
| RSP | Sell | INVESCO EXCHANGE TRADED FD Ts&p500 eql wgt | $4,138,000 | -60.3% | 30,827 | -53.3% | 1.27% | -49.4% |
| INNV | Sell | INNOVAGE HLDG CORP | $1,479,000 | -32.6% | 337,748 | -1.2% | 0.46% | -14.2% |
| IEMG | Sell | ISHARES INCcore msci emkt | $203,000 | -40.5% | 4,142 | -32.5% | 0.06% | -24.4% |
| HMLP | Exit | HOEGH LNG PARTNERS LP | $0 | – | -20,000 | -100.0% | -0.04% | – |
| CP | Exit | CANADIAN PAC RY LTD | $0 | – | -2,475 | -100.0% | -0.05% | – |
| KWR | Exit | QUAKER HOUGHTON | $0 | – | -1,296 | -100.0% | -0.05% | – |
| PLD | Exit | PROLOGIS INC. | $0 | – | -2,200 | -100.0% | -0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIDERS INDEX | 42 | Q3 2023 | 52.7% |
| Alphabet Inc-Cl C | 32 | Q3 2023 | 6.3% |
| BLACKSTONE GROUP INC | 32 | Q3 2023 | 4.4% |
| HUMANA INC | 29 | Q3 2023 | 5.9% |
| CVS HEALTH CORP | 28 | Q4 2022 | 5.0% |
| Paypal Inc | 27 | Q3 2023 | 4.4% |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC | 26 | Q3 2019 | 4.5% |
| Proctor & Gamble | 26 | Q3 2019 | 0.9% |
| UNITED TECHNOLOGIES | 26 | Q3 2019 | 0.2% |
| VANGUARD WORLD FDS | 25 | Q3 2023 | 41.4% |
View WELCH CAPITAL PARTNERS LLC/NY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HEALTHTRONICS SURGICAL SERVICES INC | February 12, 2004 | 9 | 11.0% |
| HMS HOLDINGS CORP | February 12, 2004 | 9 | 11.0% |
| REGENERATION TECHNOLOGIES INC | February 12, 2004 | 9 | 11.0% |
| SONUS PHARMACEUTICALS INC | February 12, 2004 | 9 | 11.0% |
| DRAXIS HEALTH INC /CN/ | March 07, 2003 | 9 | 11.0% |
| PRAECIS PHARMACEUTICALS INC | March 04, 2003 | 9 | 11.0% |
View WELCH CAPITAL PARTNERS LLC/NY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-17 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-08 |
| 13F-HR | 2021-11-04 |
View WELCH CAPITAL PARTNERS LLC/NY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.